Anti-AKT1 (phospho S473) 抗体 [EP2109Y]
Anti-AKT1 (phospho S473) antibody [EP2109Y]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- 了解详情
4
(10 Reviews)
|
(763 Publications)
Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) is a rabbit monoclonal antibody detecting AKT1 in Western Blot, IHC-P, ELISA, Dot Blot. Suitable for Human, Mouse, Rat,.
- Biophysical QC for unrivalled batch-batch consistency
- Over 610 publications
- Trusted since 2009
查看别名
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
ab81283, at 1/100 dilution, staining AKT1 in untreated (left panel) and Phosphatase-treated (right panel) human cervical carcinoma by Immunohistochemistry using formalin-fixed, paraffin-embedded tissue
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- FuncS
Unknown
Functional Studies - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
MCF7 cells were incubated at 37°C for 2 hours with vehicle control (0 μM) and different concentrations of CCCP (ab141229). Increased expression of AKT1 (phospho S473) (ab81283) in MCF7 cells correlates with an increase in CCCP concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 10μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab81283 at 2 μg/ml and ab8227 at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 and visualised using ECL development solution.
- In-Cell ELISA
Unknown
In-Cell ELISA - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
NIH3T3 cells were starved overnight and treated with PDGF 50ng/mL or vehicle control for 1 hour prior to fixation with 4% paraformaldehyde. Levels of total Akt were measured using antibody ab81283 on an infrared in cell ELISA assay platform.
- WB
Lab
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) at 0.259 µg/mL
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell) grown in serum free media overnight, whole cell lysate at 10 µg
Lane 2:
HeLa grown in serum free media overnight, then treated with 150nM Insulin for 5min, whole cell lysate at 10 µg
Lane 3:
HeLa grown in serum free media overnight, then treated with 150nM Insulin for 5min, whole cell lysate. Then the membrane was incubated with alkaline phosphatase at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 55 kDa
false
- WB
Lab
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
Insulin treatment : cells were starved overnight and then treated for 20 min (Insulin) at 100 ng/ml.
Phosphatase treatment : membrane strips were incubated with 200 ul of phosphatase (150 U/ml) at 37 degrees for 1 hour.
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) at 1/1000 dilution
All lanes:
HEK293 cell lysate
Predicted band size: 55 kDa
false
- WB
Lab
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) at 0.259 µg/mL
Lane 1:
LNCaP (human prostate carcinoma epithelial cell) whole cell lysate at 10 µg
Lane 2:
LNCaP treated with 100nM Cacyculin A for 30min whole cell lysate at 10 µg
Lane 3:
LNCaP treated with 100nM Cacyculin A for 30min whole cell lysate. Then the membrane was incubated with alkaline phosphatase at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 55 kDa
false
- WB
Unknown
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
Primary : All Lanes : Anti AKT1 (phospho S473) antibody (ab81283) at 1 : 5000 dilution. Lane 1 = AKT1 (His tag) full length recombinant protein ab62279 - 50ng. Lane 2 = NIH3T3 serum starved overnight, 15ug. Lane 3 = NIH3T3 serum starved overnight and treated with PDGF-AB 50ng/mL for 1 hour, 15ug. Secondary : Lanes 1-3 : Goat polyclonal to Rabbit IgG H&L Pre-Adsorbed (HRP) at 1 : 5000 developed using the ECL technique. Performed under reducing conditions (50mM DTT, Sample heated at 60°C). Predicted band size : 56kDa. Observed band size : 56kDa. Blocking step : 5% Milk in 50mM Tris+0.05% Tween for 1 hour at RT. Primary antibody buffer : 5% BSA in 50mM Tris+0.05% Tween overnight. Secondary antibody buffer : 5% Milk in 50mM Tris+0.05% Tween for 2 hours at RT. Exposure time : 5 minutes
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283)
Predicted band size: 55 kDa
false
- WB
Lab
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
PDGF treatment : cells were starved overnight and then treated for 1 h with PDGF at 100 ng/ml.
Phosphatase treatment : membrane strips were incubated with 200 ul of phosphatase (150 U/ml) at 37 degrees for 1 hour.
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) at 1/1000 dilution
All lanes:
NIH/3T3 cell lysate
Predicted band size: 55 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
Blocking buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) at 1/25000 dilution
Lane 1:
NIH/3T3 (Mouse embryonic fibroblast) treated with 100ng/ml PDGF for 1 hour whole cell lysates at 15 µg
Lane 2:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 55 kDa
Observed band size: 56 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
PC12 cells were incubated at 37°C for 24 hours with vehicle control (0 nM) and 1 μM of Galanin (1-15) (porcine, rat) (ab 141152). Decreased expression of AKT1 (phospho S473) (ab81283) in PC12 cells correlates with an increase in Galanin (1-15) (porcine, rat) concentration, as described in literature.
Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate), 30μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 3% milk before being incubated withab81283at 1 μg/ml andab8227at 1 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 and visualised using ECL development solution.
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283)
Predicted band size: 55 kDa
Observed band size: 60 kDa
true
Exposure time: 20min
- WB
Lab
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
The basal expression level of AKT1 (phospho S473) varies in different cell lines reported by PMID : 19372546. But to detect clear signal, treatment is strongly recommended when using this antibody.
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) at 1/1000 dilution
Lane 1:
LNCaP (Human prostate carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
LNCaP (Human prostate carcinoma epithelial cell) treated with 0.1 uM Calyculin A for 30 minutes whole cell lysates at 20 µg
Lane 3:
A549 (Human lung carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 4:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 5:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 6:
HUVEC (Human umbilical vein endothelial cell) whole cell lysates at 20 µg
Lane 7:
C2C12 (Mouse myoblasts myoblast) whole cell lysates at 20 µg
Lane 8:
Mouse brain lysates at 20 µg
Lane 9:
Rat heart lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 55 kDa
false
Exposure time: 50s
- Dot
Unknown
Dot Blot - Anti-AKT1 (phospho S473) antibody [EP2109Y] (AB81283)
Dot blot analysis of AKT1 (phospho S473) phospho peptide (Lane 1) and AKT1 non-phospho peptide (Lane 2) labelling AKT1 (phospho S473) phospho peptide with ab81283 at a dilution of 1 : 1000 dilution (0.259μg/ml). A Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) was used as the secondary antibody at a dilution of 1 : 20,000 dilution.
Blocking buffer : 5% NFDM/TBST. Dilution buffer : 5% NFDM /TBST.
不同偶联物与剂型 (4)
-
HRP Anti-AKT1 (phospho S473) antibody [EP2109Y]
-
Anti-AKT1 (phospho S473) antibody [EP2109Y] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-AKT1 (phospho S473) antibody [EP2109Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-AKT1 (phospho S473) antibody [EP2109Y]
反应性数据
产品详情
Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Dot blot, IHC-P, In-Cell ELISA, WB in human, mouse, rat, recombinant fragment samples.
Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) has been cited over 612 times in peer reviewed journals and is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-phospho AKT antibody (Anti-RAC antibody; anti-pAKT antibody) [EP2109Y] (ab81283) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) has 10 independent reviews from customers.
Anti-AKT1 (phospho S473) antibody [EP2109Y] (ab81283) specifically detects AKT1 Phospho-S473 (UniProt ID: P31749; Molecular weight: 56kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone EP2109Y - ab215873.
Antibody clone EP2109Y is also available pre-conjugated to a variety of labels for your convenience - HRP, Alexa Fluor® 488, Alexa Fluor® 647 (ab194201, ab313593, ab313670).
AKT1 (RAC) also known as protein kinase B (PKB), is a crucial component of the PI3K/AKT signaling pathway, which regulates cell growth, survival, and metabolism. It interacts with key cell cycle proteins like p21, p27, and cyclin D1, and tumor suppressors such as p53. In oncology, AKT1 is a significant target due to its role in promoting tumor growth by enhancing cell proliferation and inhibiting apoptosis.
Abcam recommended secondaries - Goat Anti-Rabbit HRP (ab205718) and Goat Anti-Rabbit Alexa Fluor® 488 (ab150077). Or search our wide range of secondary antibodies for use with your experiment.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT1 regulates a broad spectrum of cellular functions through signaling pathways. It is an important player in the phosphatidylinositol 3-kinase (PI3K) and AKT pathway forming part of a complex involved in promoting cell survival and growth. AKT1 interacts closely with other proteins such as mTOR influencing cellular metabolism and autophagy. The phosphorylation state of AKT1 is critical for its activity with modifications like p-AKT S473 impacting its interaction with cellular substrates.
Pathways
AKT1 participates in the PI3K/AKT/mTOR signaling cascade instrumental in cell proliferation and metabolism. AKT1 integrates signals from insulin and growth factors modulating pathways that control cell growth and glucose uptake. This pathway involves proteins like mTOR and phospho-AKT which coordinate cellular responses to external stimuli. AKT1’s phosphorylation at serine 473 and the involvement of AKT1 E17K a gain-of-function mutation influence these pathways significantly.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (763)
Recent publications for all applications. Explore the full list and refine your search
Journal of inflammation research 18:13575-13592 PubMed41054626
2025
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 13:e70553 PubMed40969143
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in chemistry 13:1650197 PubMed40919243
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature genetics 57:2192-2202 PubMed40846762
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 53:737-753 PubMed40801020
2025
Applications
Unspecified application
Species
Unspecified reactive species
International neurourology journal 29:S44-S52 PubMed40776597
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:27739 PubMed40730854
2025
Applications
Unspecified application
Species
Unspecified reactive species
Iranian journal of basic medical sciences 28:946-954 PubMed40703755
2025
Applications
Unspecified application
Species
Unspecified reactive species
Toxics 13: PubMed40559960
2025
Applications
Unspecified application
Species
Unspecified reactive species
Reproductive biology and endocrinology : RB&E 23:91 PubMed40537830
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com